U.S. markets close in 1 hour 59 minutes

Enzo Biochem, Inc. (ENZ)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
1.27000.0000 (0.00%)
A partir del 01:46PM EDT. Mercado abierto.

Enzo Biochem, Inc.

81 Executive Blvd.
Suite 3
Farmingdale, NY 11735
United States
631 755 5500
https://www.enzo.com

Sector(es)Healthcare
IndustriaDiagnostics & Research
Empleados a tiempo completo179

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Ms. Kara CannonChief Executive Officer990.78kN/D1970
Dr. Elazar Rabbani Ph.D.Co-Founder & Director50kN/D1943
Ms. Patricia Eckert CPAChief Financial Officer400.06kN/D1978
Mr. Matthew KupferbergGeneral Counsel & SecretaryN/DN/D1966
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Gestión corporativa

La calificación ISS Governance QuickScore de Enzo Biochem, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.